- Home
- / Hunan Nucien Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Hunan Nucien Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥7.3
2024-10-29
Revenue
¥258.4 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 16, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 690.7M | 1.0B | 1.1B | 673.7M | 689.4M | 710.2M | 258.4M |
| Cost of goods sold | 101.0M | 115.5M | 109.6M | 91.1M | 99.3M | 111.8M | 119.6M |
| Gross profit | 589.7M | 885.5M | 964.9M | 583.2M | 590.1M | 598.4M | 138.9M |
| Gross profit margin, % | 85.4% | 88.5% | 89.8% | 86.6% | 85.6% | 84.3% | 53.7% |
| Operating expense total | 474.6M | 716.0M | 766.2M | 654.6M | 499.0M | 462.3M | 168.3M |
| Depreciation and amortization | 40.1M | 37.3M | 35.3M | 54.3M | 49.4M | 35.9M | 69.4M |
| EBITDA | 115.2M | 169.5M | 198.7M | (71.4M) | 91.1M | 136.1M | (29.4M) |
| EBITDA margin, % | 16.7% | 16.9% | 18.5% | -10.6% | 13.2% | 19.2% | -11.4% |
| EBIT | 78.1M | 125.4M | 138.8M | (223.8M) | (62.9M) | 10.8M | (390.1M) |
| EBIT margin, % | 11.3% | 12.5% | 12.9% | -33.2% | -9.1% | 1.5% | -151.0% |
| Interest income | 276.0K | 1.1M | 7.6M | 18.1M | 16.8M | 10.8M | 7.0M |
| Interest expense | 14.3M | 15.5M | 13.4M | 15.9M | 22.0M | 15.2M | 5.4M |
| Pre tax profit | 64.0M | 110.6M | 141.2M | (221.6M) | (74.0M) | (9.1M) | (388.6M) |
| Income tax expense | 1.5M | 13.2M | 1.1M | (33.3M) | 23.6M | 1.7M | 8.6M |
| Net Income | 62.4M | 97.5M | 140.0M | (188.2M) | (97.6M) | (10.8M) | (397.3M) |